Literature DB >> 1604481

Diminished anticoagulant and fibrinolytic activity following liver transplantation.

F Velasco1, R Villalba, M Fernandez, M de la Mata, J Roman, V Rubio, S Rufian, E Varo, C Pera, A Torres.   

Abstract

This study analyzed the coagulation changes in twenty patients after orthotopic liver transplantation. The procoagulant, anticoagulant, and fibrinolytic systems were studied during the first two postoperative weeks. Within the first postoperative day all extrinsic and intrinsic pathway factors became normal except factors IX, VII, and X, which recovered within the next 24 hr. Of interest are the changes in factor VIII, which reached a high concentration with an increase in its antigenic fraction during the study. However, coagulation inhibitors showed a different pattern. In fact, antithrombin III (AT-III) and protein C (PC) needed from 7 to 14 days to reach normal values. Total protein S (TPS) and free protein S (FPS) did not recover until day 7, whereas heparin cofactor II (HC-II) remained at subnormal levels throughout the study. Thrombin-antithrombin III complex (TAT) values were strikingly elevated in the immediate postoperative period. Fibrinolysis parameters showed plasminogen (PL) levels in the normal range until day 4. Antiplasmin (AP) followed a curve parallel to that of plasminogen but its levels were higher during this observation period. Similarly the initial elevation in plasminogen activator inhibitor 1 endothelial type (PAI-1) levels remained high until days 4 and 7. In summary, it can be concluded that during the postoperative phase after OLT a hypercoagulable state is developed as a result of diminished anticoagulant and fibrinolytic activity. This coagulation might be a nontechnical factor contributing to the thrombotic vascular complications of some liver recipients.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1604481     DOI: 10.1097/00007890-199206000-00017

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  3 in total

1.  Pharmacokinetics of human antithrombin III concentrate in the immediate postoperative period after liver transplantation.

Authors:  Bo Rim Kim; Jaeseong Oh; Kyung-Sang Yu; Ho Geol Ryu
Journal:  Br J Clin Pharmacol       Date:  2020-02-18       Impact factor: 4.335

2.  Feasibility and effectiveness of a new algorithm in preventing hepatic artery thrombosis after liver transplantation.

Authors:  Sascha A Müller; Bruno M Schmied; Arianeb Mehrabi; Thilo Welsch; Peter Schemmer; Ulf Hinz; Jürgen Weitz; Jens Werner; Markus W Büchler; Jan Schmidt
Journal:  J Gastrointest Surg       Date:  2008-11-26       Impact factor: 3.452

3.  Deep Vein Thrombosis and Pulmonary Embolism in Liver Transplant Patients: Risks and Prevention.

Authors:  James Yip; David A Bruno; Charlotte Burmeister; Marwan Kazimi; Atsushi Yoshida; Marwan S Abouljoud; Gabriel T Schnickel
Journal:  Transplant Direct       Date:  2016-03-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.